PEAK6
RGNX icon

PEAK6’s Regenxbio RGNX Stock Holding History

PEAK6’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264K Buy
+22,000
New +$183K ﹤0.01% 2196

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

PEAK6's RGNX Position: Q2 2026 in Review

PEAK6 opened a new position in Regenxbio (RGNX) in Q2 2026: 22,000 shares worth $264K. The stake represents ﹤0.01% of the portfolio and ranks #2196 among its holdings.

165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • PEAK6 held 22,000 shares of Regenxbio worth $264K as of Q2 2026.
  • Regenxbio was a new PEAK6 position in Q2 2026.
  • Regenxbio made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2196 holding.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.